Skip to main content
Premium Trial:

Request an Annual Quote

Pathway Genomics, Susan G. Komen Partner on Breast Cancer Screening

NEW YORK (GenomeWeb News) – Pathway Genomics and Susan G. Komen today said they are partnering to educate women about screening options available for detecting a genetic predisposition for breast cancer.

San Diego-based Pathway will provide financial support and genetic testing for women in need at no charge, as part of the partnership, which follows a decision by the US Supreme Court two weeks ago that invalidated patents held by Myriad Genetics covering the BRCA1 and BRCA2 genes. The court, however, said that Myriad's methods applying knowledge about the genes are patentable.

Shortly after the SCOTUS decision, Pathway Genomics announced its plans to offer BRCA1/2 testing as part of its Hereditary Cancer DNA Insight test, which is scheduled to launch in August. As reported by Clinical Sequencing News, it is one of several companies, labs, and academic centers that have said that they will begin, or already have begun, offering BRCA testing.

"Providing patients with proper education and affordable hereditary cancer screening is extremely important to Pathway Genomics and will help pave the way to saving thousands of lives each year," company Founder and CEO Jim Plante said in a statement.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.